Literature DB >> 14736238

Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.

Shaoman Zhou1, Julie M Breitenbach, Katherine Z Borysko, John C Drach, Earl R Kern, Elizabeth Gullen, Yung-Chi Cheng, Jiri Zemlicka.   

Abstract

The second generation of methylenecyclopropane analogues of nucleosides 5a-5i and 6a-6i was synthesized and evaluated for antiviral activity. The 2,2-bis(hydroxymethyl)methylenecyclopropane (11) was converted to dibromo derivative 7 via acetate 12. Alkylation-elimination of adenine (16) with 7 afforded the Z/E mixture of acetates 17 + 18, which was deacetylated to give analogues 5a and 6a separated by chromatography. A similar reaction with 2-amino-6-chloropurine (19) afforded acetates 20 + 21 and, after deprotection and separation, isomers 5f and 6f. The latter served as starting materials for synthesis of analogues 5b, 5e, 5g-5i and 6b, 6e, 6g-6i. Alkylation-elimination of N(4)-acetylcytosine (22) with 7 afforded a mixture of isomers 5c + 6c which were separated via N(4)-benzoyl derivatives 23 and 24. Deprotection furnished analogues 5c and 6c. Alkylation of 2,4-bis(trimethylsilyloxy)-5-methylpyrimidine (25) with 7 led to bromo derivative 26. Elimination of HBr followed by deacetylation and separation gave thymine analogues 5d and 6d. The guanine Z-isomer 5b was the most effective against human and murine cytomegalovirus (HCMV and MCMV) with EC(50) = 0.27-0.49 microM and no cytotoxicity. The 6-methoxy analogue 5g was also active (EC(50) = 2.0-3.5 microM) whereas adenine Z-isomer 5a was less potent (EC(50) = 3.6-11.7 microM). Cytosine analogue 5c was moderately effective, but 2-amino-6-cyclopropylamino derivative 5e was inactive. All E-isomers were devoid of anti-CMV activity, and none of the analogues was significantly active against herpes simplex viruses (HSV-1 or HSV-2). The potency against Epstein-Barr virus (EBV) was assay-dependent. In Daudi cells, the E-isomers of 2-amino-6-cyclopropylamino- and 2,6-diaminopurine derivatives 6e and 6h were the most potent (EC(50) approximately 0.3 microM), whereas only the thymine Z-isomer 5d was active (EC(50) = 4.6 microM). Guanine Z-derivative 5b was the most effective compound in H-1 cells (EC(50) = 7 microM). In the Z-series, the 2-amino-6-methoxypurine analogue 5g was the most effective against varicella zoster virus (VZV, EC(50) = 3.3 microM) and 2,6-diaminopurine 5h against hepatitis B virus (HBV, EC(50) = 4 microM). Adenine analogues 5a and 6a were moderately active as substrates for adenosine deaminase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736238     DOI: 10.1021/jm030316s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

Review 1.  Progress in the development of new therapies for herpesvirus infections.

Authors:  Nathan B Price; Mark N Prichard
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

2.  Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.

Authors:  Sunwen Chou; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  Synthesis of Methylenecyclopropane Analogues of Antiviral Nucleoside Phosphonates.

Authors:  Zhaohua Yan; Shaoman Zhou; Earl R Kern; Jiri Zemlicka
Journal:  Tetrahedron       Date:  2006-03-13       Impact factor: 2.457

Review 4.  The search for new therapies for human cytomegalovirus infections.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Virus Res       Date:  2010-11-21       Impact factor: 3.303

5.  Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase.

Authors:  Chengwei Li; Brian G Gentry; John C Drach; Jiri Zemlicka
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-09       Impact factor: 1.381

6.  A New Alkylation-Elimination Method for Synthesis of Antiviral Fluoromethylenecyclopropane Analogues of Nucleosides.

Authors:  Shaoman Zhou; Jiri Zemlicka
Journal:  Tetrahedron       Date:  2005-07-25       Impact factor: 2.457

7.  In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.

Authors:  Earl R Kern; Nicole L Kushner; Caroll B Hartline; Stephanie L Williams-Aziz; Emma A Harden; Shaoman Zhou; Jiri Zemlicka; Mark N Prichard
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides.

Authors:  John D Williams; Atiyya R Khan; Emma A Harden; Caroll B Hartline; Geraldine M Jefferson; Kathy A Keith; Mark N Prichard; Jiri Zemlicka; Norton P Peet; Terry L Bowlin
Journal:  Bioorg Med Chem       Date:  2012-05-01       Impact factor: 3.641

9.  Anti-BK virus activity of nucleoside analogs.

Authors:  Parmjeet Randhawa; Jiri Zemlicka; Andreas Sauerbrei; Chris Meier; Karl Y Hostetler; James R Beadle; Noush Afarin Farasati; Yuchen Huang; Matthews Bradley
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

10.  Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.

Authors:  Han Chen; Chengwei Li; Jiri Zemlicka; Brian G Gentry; Terry L Bowlin; Donald M Coen
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.